Streetbeat News

Analyst Ratings

NVO

Financial giants are showing a bullish sentiment towards Novo Nordisk (NYSE:NVO) with 70% of options traders being bullish. The stock is currently trading at $123.26, down by 3.33%, and analysts have set an average target price of $160.0. The options market indicates a focus on a price range between $120.0 and $175.0.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 2:16 pm

CORZ

Whales are showing a bullish stance on Core Scientific (NASDAQ:CORZ) with 72% of recent options trades being bullish. Analysts have set an average price target of $17.25, with some downgrades in ratings. The stock is currently trading at $12.36, up by 3.17%.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 2:16 pm

EXPE

Cantor Fitzgerald has reiterated its Neutral rating on Expedia Group, maintaining a price target of $130.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 2:14 pm

URI

JP Morgan analyst Tami Zakaria has maintained an Overweight rating on United Rentals (NYSE:URI) and raised the price target from $780 to $940.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 2:13 pm

ETSY

Cantor Fitzgerald analyst Deepak Mathivanan has reiterated a Neutral rating on Etsy, maintaining a price target of $50.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 2:13 pm

EBAY

Cantor Fitzgerald has reiterated a Neutral rating on eBay with a maintained price target of $62.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 2:12 pm

SBAC

JP Morgan analyst Richard Choe maintains a Neutral rating on SBA Communications (NASDAQ:SBAC) but raises the price target from $228 to $250.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 2:11 pm

MRNS

Oppenheimer analyst Jay Olson has upgraded Marinus Pharma (NASDAQ:MRNS) from Perform to Outperform, setting a price target of $6.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 2:11 pm

GM

NVO

Oil prices increased due to tensions in the Middle East. Bernstein downgraded General Motors (GM) stock, and Novo Nordisk (NVO) faced a decline following pricing criticism from Senator Sanders.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 2:10 pm

LEN

JP Morgan analyst Michael Rehaut maintains a Neutral rating on Lennar (NYSE:LEN) but raises the price target from $154 to $173.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 2:09 pm